DE3579617D1 - Lebender gereinigter impfstoff gegen die marek'sche krankheit. - Google Patents

Lebender gereinigter impfstoff gegen die marek'sche krankheit.

Info

Publication number
DE3579617D1
DE3579617D1 DE8585200461T DE3579617T DE3579617D1 DE 3579617 D1 DE3579617 D1 DE 3579617D1 DE 8585200461 T DE8585200461 T DE 8585200461T DE 3579617 T DE3579617 T DE 3579617T DE 3579617 D1 DE3579617 D1 DE 3579617D1
Authority
DE
Germany
Prior art keywords
disease
marek
virus
mdv
monovalent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585200461T
Other languages
English (en)
Inventor
Boer Gerben Foppe De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centraal Diergeneeskundig Instituut
Original Assignee
Centraal Diergeneeskundig Instituut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centraal Diergeneeskundig Instituut filed Critical Centraal Diergeneeskundig Instituut
Application granted granted Critical
Publication of DE3579617D1 publication Critical patent/DE3579617D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE8585200461T 1984-04-09 1985-03-25 Lebender gereinigter impfstoff gegen die marek'sche krankheit. Expired - Lifetime DE3579617D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8401120A NL8401120A (nl) 1984-04-09 1984-04-09 Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek.

Publications (1)

Publication Number Publication Date
DE3579617D1 true DE3579617D1 (de) 1990-10-18

Family

ID=19843774

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585200461T Expired - Lifetime DE3579617D1 (de) 1984-04-09 1985-03-25 Lebender gereinigter impfstoff gegen die marek'sche krankheit.

Country Status (17)

Country Link
US (1) US4673572A (de)
EP (1) EP0159743B1 (de)
JP (1) JPS6123A (de)
AT (1) ATE56364T1 (de)
AU (1) AU574164B2 (de)
CA (1) CA1251397A (de)
DD (1) DD232822A5 (de)
DE (1) DE3579617D1 (de)
ES (1) ES8605680A1 (de)
HU (1) HU194496B (de)
IL (1) IL74809A (de)
IN (1) IN163229B (de)
MX (1) MX7718E (de)
NL (1) NL8401120A (de)
WO (1) WO1985004588A1 (de)
YU (1) YU44687B (de)
ZA (1) ZA852564B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456101A (en) * 1980-11-08 1984-06-26 Honda Giken Kogyo Kabushiki Kaisha Vehicular brake operating system
JP2508625B2 (ja) * 1985-08-30 1996-06-19 ソニー株式会社 半導体レ−ザ−
FR2598596B1 (fr) * 1986-05-15 1990-10-19 Sanofi Elf Bio Ind Procede de traitement du lait en vue de l'obtention de fromages
US5849299A (en) * 1991-06-28 1998-12-15 The United States Of America As Represented By The Secretary Of Agriculture Attenuated revertant serotype 1 marek's disease vaccine
WO1993023078A1 (en) * 1992-05-19 1993-11-25 Viktoria Alexeevna Lukina Vaccine for prophylaxis of marek disease of birds and method of its preparation
IL114501A (en) * 1994-07-14 1999-08-17 Akzo Nobel Nv Marek's disease virus vaccine
EP0703294A1 (de) * 1994-07-14 1996-03-27 Akzo Nobel N.V. Virusimpfstoff gegen Mareksche Krankheit
EP0748867A1 (de) * 1995-06-12 1996-12-18 Duphar International Research B.V Marek-Krankheit Vakzine
US5989805A (en) * 1995-10-27 1999-11-23 Board Of Trustees Operating Michigan State University Immortal avian cell line to grow avian and animal viruses to produce vaccines
CA2257409A1 (en) * 1996-06-04 1997-12-11 University Of Georgia Research Foundation, Inc. Modified live avian polyomavirus vaccine in psittacine birds
EP1038952A3 (de) * 1998-12-09 2001-06-27 Pfizer Products Inc. Verfahren zur Herstellung von Mareks Disease Virus (MDV) unter Verwendung von kontinuierlichen Vogelzellinien
EA030866B1 (ru) 2012-03-22 2018-10-31 Мериал, Инк. Модифицированный вирус болезни марека и вакцины на его основе

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1292803A (en) * 1968-11-18 1972-10-11 Nat Res Dev Improvements relating to the production of antigens
US3642574A (en) * 1970-04-29 1972-02-15 Us Agriculture Method for producing vaccine for immunization of poultry against marek{3 s disease
US3783098A (en) * 1971-08-10 1974-01-01 Cornell Res Foundation Inc Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same
US4160024A (en) * 1978-05-01 1979-07-03 Cornell Research Foundation, Inc. Marek's disease vaccine

Also Published As

Publication number Publication date
NL8401120A (nl) 1985-11-01
YU59985A (en) 1988-06-30
ZA852564B (en) 1985-11-27
ES541930A0 (es) 1986-04-16
DD232822A5 (de) 1986-02-12
AU574164B2 (en) 1988-06-30
AU4156185A (en) 1985-11-01
EP0159743B1 (de) 1990-09-12
IN163229B (de) 1988-08-27
WO1985004588A1 (en) 1985-10-24
ES8605680A1 (es) 1986-04-16
JPH0317808B2 (de) 1991-03-11
EP0159743A1 (de) 1985-10-30
CA1251397A (en) 1989-03-21
YU44687B (en) 1990-12-31
IL74809A0 (en) 1985-07-31
HUT38542A (en) 1986-06-30
US4673572A (en) 1987-06-16
JPS6123A (ja) 1986-01-06
ATE56364T1 (de) 1990-09-15
MX7718E (es) 1990-10-10
HU194496B (en) 1988-02-29
IL74809A (en) 1990-09-17

Similar Documents

Publication Publication Date Title
DE3579617D1 (de) Lebender gereinigter impfstoff gegen die marek'sche krankheit.
Cubillos et al. Characterisation of strains of infectious bronchitis virus isolated in Chile
EP0125245B1 (de) Kultivierung von hämorrhagische enteritis hervorrufenden viren in truthahn-gewebe-zellkulturen
ALLEN et al. Role of coexpression of IL-2 and herpes simplex virus proteins in recombinant vaccinia virus vectors on levels of induced immunity
MXPA01005808A (es) Cepa de virus de enfermedad bursal infecciosa para administracion en huevo.
DZ1550A1 (fr) Vaccin depourvu de cellules contre le virus de la maladie marek.
Han et al. Comparison of virulence and restriction endonuclease cleavage patterns of infectious laryngotracheitis viruses isolated in Korea
Carmichael et al. Small-plaque variant of canine herpesvirus with reduced pathogenicity for newborn pups
NZ272548A (en) Attenuated strain of mareks disease virus (a herpes virus) and its use in poultry vaccines
Wiebe et al. Virion envelope glycoproteins as epidermiological markers of Venezuelan encephalitis virus isolates
US4213965A (en) Small-plaque variant canine herpesvirus vaccine
Eisenstein et al. Salmonella vaccines: Protection by endotoxin protein and lipopolysaccharide in two different mouse strains.
JPS5756430A (en) Live virus vaccine for canine parainfluenza
Thompson et al. Cytotoxic activity of cells recovered from the respiratory tracts of chickens inoculated with infectious bronchitis virus
JPS6222727A (ja) 感染性気管支炎ワクチン
CA1289881C (en) Vaccine against herpes simplex
JP3040157B2 (ja) イヌパルボウイルス（ｃｐｖ）を含む弱毒イヌパルボウイルスワクチンとイヌ科動物におけるｃｐｖ感染予防
EP1161953A3 (de) IBDV Stamm für in ovo Verabreichung
SU1707075A1 (ru) Штамм вируса болезни Марека дл изготовлени вакцины против болезни Марека
KR960016906A (ko) 약독화 수두 생바이러스 백신 및 그의 제조방법
岡崎和子 et al. The immunodominant glycoprotein complex of equid herpesvirus 1 (EHV-1) and the counterpart of EHV-4.
EP0703294A1 (de) Virusimpfstoff gegen Mareksche Krankheit
Lung et al. Natural Epstein-Barr Virus Isolates from Southern China and California Differ in the Bam Hl I Region
Shibuta Production of pertussis toxin mutant protein by Bordetella pertussis variant for use in whooping cough vaccine preparation
RO96364B1 (ro) PROCEDEU DE PREPARARE A UNUI VACCIN VIU PURIFICAT îMPOTRIVA BOLII LUI MAREK

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee